These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 7098475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interaction of estradiol and estriol with uterine estrogen receptor in vivo and in excised uteri or cell suspensions at 37 C: noncooperative estradiol binding and absence of estriol inhibition of estradiol-induced receptor activation and transformation.
    Müller RE, Traish AM, Wotiz HH.
    Endocrinology; 1985 Nov; 117(5):1839-47. PubMed ID: 4042965
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of the dextran-coated charcoal assay for estradiol receptor in breast cancer preparations.
    Shafie S, Brooks SC.
    J Lab Clin Med; 1979 Nov; 94(5):784-98. PubMed ID: 501205
    [Abstract] [Full Text] [Related]

  • 6. Estriol and estradiol interactions with the estrogen receptor in vivo and in vitro.
    Müller RE, Beebe DM, Bercel E, Traish AM, Wotiz HH.
    J Steroid Biochem; 1984 Apr; 20(4B):1039-46. PubMed ID: 6727349
    [Abstract] [Full Text] [Related]

  • 7. Estriol binding in uterine corpus cancer and in normal uterine tissues.
    Iida K, Imai A, Tamaya T.
    Gen Pharmacol; 1991 Apr; 22(3):491-3. PubMed ID: 1869022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Affinity of estradiol mustard for estrogen receptors and its enzymatic degradation in uterine and breast cancer cytosols.
    Leclercq G, Deboel MC, Heuson JC.
    Int J Cancer; 1976 Dec 15; 18(6):750-6. PubMed ID: 992905
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Estradiol entry into endometrial cells in suspension.
    De Ryck LM, Ross JB, Petra PH, Gurpide E.
    J Steroid Biochem; 1985 Aug 15; 23(2):145-52. PubMed ID: 3928973
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of an estrogen-sensitive cell line established from normal rat endometrium.
    Sonnenschein C, Weiller S, Farookhi R, Soto AM.
    Cancer Res; 1974 Nov 15; 34(11):3147-54. PubMed ID: 4417560
    [No Abstract] [Full Text] [Related]

  • 16. Roles of antiestrogen binding sites in human endometrial cancer cells.
    Hayashida M, Terakawa N, Shimizu I, Ikegami H, Wakimoto H, Aono T, Tanizawa O, Matsumoto K.
    J Steroid Biochem; 1987 Jun 15; 26(6):705-11. PubMed ID: 3613570
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y, Sato B, Noma K, Kishimoto S, Koizumi K, Aono T, Matsumoto K.
    Cancer Res; 1983 Sep 15; 43(9):4091-7. PubMed ID: 6871850
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The dissociation rate of estrogen receptor-ligand complexes is increased by high concentrations of steroids and antiestrogens.
    Borgna JL, Ladrech S.
    Mol Cell Endocrinol; 1982 Jun 15; 27(1):1-15. PubMed ID: 7106368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.